RAJKUMAR VENKATRAMANI to Time-to-Treatment
This is a "connection" page, showing publications RAJKUMAR VENKATRAMANI has written about Time-to-Treatment.
Connection Strength
0.186
-
Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology Group. Cancer. 2021 01 15; 127(2):275-283.
Score: 0.149
-
Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors. Pediatr Blood Cancer. 2020 10; 67(10):e28417.
Score: 0.037